Kintor Pharmaceutical : Pharma Announced Completion of Phase I Trial of the World’s First PROTAC Compound (GT20029) for Topical Use

Suzhou, November 24, 2022 – Kintor Pharmaceutical Limited (“Kintor Pharma”, HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, today announced the top-line results for its phase I clinical trial of GT20029 for the treatment of androgenetic alopecia (AGA) and acne in China, which demonstrated the good safety, tolerability and pharmacokinetics … Read more

Regeneron’s Eylea Win Leaves an Elephant in the Room

The world’s largest drug developers typically generate revenue from a portfolio of approved drugs, but some have grown dangerously dependent on a single product. AbbVie (ABBV) leaned on Humira sales in the US for 31% of total global revenue in 2021. That presents a problem when the drug loses patent exclusivity in summer 2023. Indeed, … Read more

Arcaea Acquires Gadusol To Speed ​​Development Of Natural Sunscreen That Protects You Like A Fish

The zebrafish shares a similar genetic structure to humans. AFP via Getty Images Have you ever seen a fish wearing sunblock? Of course not, because they possess natural compounds that protect them from the negative effects of that big yellow star in the sky. Gadusol Laboratories, an Oregon State University spinout founded five years ago … Read more